Medpace Holdings, Inc. (MEDP) financial statements and ratios from SEC XBRL: revenue $2.9B (TTM), net margin 17.8%, revenue growth 20.0% YoY, P/E 35.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $2.53B |
| Revenue (TTM) | $2.9B |
| Net Margin | 17.8% |
| Operating Margin (TTM) | 20.9% |
| Revenue Growth (YoY) | 20.0% |
| EPS Growth (YoY) | 19.8% |
| FCF Growth (YoY) | 19.2% |
| P/E Ratio | 35.6 |
| EV / EBITDA | 27.8 |
| Price / Book | 39.46 |
| Price / Sales | 6.16 |
| FCF Yield | 6.2% |
| Altman Z-Score | 8.52 (safe) |
| Industry P/E (Business Services) | 30.0 |
| Sector P/E (Technology) | 34.1 |
MEDP overview · MEDP earnings · MEDP KPIs · MEDP documents · MEDP ownership · MEDP peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.